Style | Citing Format |
---|---|
MLA | Ashrafiasgarabad A, Safiri S. "Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues." Atherosclerosis, vol. 268, no. , 2018, pp. 231-232. |
APA | Ashrafiasgarabad A, Safiri S (2018). Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues. Atherosclerosis, 268(), 231-232. |
Chicago | Ashrafiasgarabad A, Safiri S. "Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues." Atherosclerosis 268, no. (2018): 231-232. |
Harvard | Ashrafiasgarabad A, Safiri S (2018) 'Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues', Atherosclerosis, 268(), pp. 231-232. |
Vancouver | Ashrafiasgarabad A, Safiri S. Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues. Atherosclerosis. 2018;268():231-232. |
BibTex | @article{ author = {Ashrafiasgarabad A and Safiri S}, title = {Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues}, journal = {Atherosclerosis}, volume = {268}, number = {}, pages = {231-232}, year = {2018} } |
RIS | TY - JOUR AU - Ashrafiasgarabad A AU - Safiri S TI - Prognostic Value of Lipoprotein-Associated Phospholipase A2 Mass for All-Cause Mortality and Vascular Events Within One Year After Acute Ischemic Stroke: Methodological Issues JO - Atherosclerosis VL - 268 IS - SP - 231 EP - 232 PY - 2018 ER - |